Search
for
Sort by
Research 30 of 133
- Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study
- SAT-127 Localization and Treatment of the Ectopic ACTH Syndrome Using Somatostatin Analogues
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery
- Mucocutaneous Manifestations of Endocrine Disorders
- Hair & Cutaneous Development
- Interventions for preventing the progression of autosomal dominant polycystic kidney disease
- Acute chylous peritonitis due to idiopathic pancreatitis mimicking acute appendicitis
- Recent advances in neuropeptide-related omics and gene editing: Spotlight on NPY and somatostatin and their roles in growth and food intake of fish
- A subpopulation of itch‐sensing neurons marked by Ret and somatostatin expression
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Human Hair Follicles Operate a Functional Peripheral Equivalent of the Hypothalamic-Pituitary-Somatotropic Axis Ex Vivo
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Virilizing insulinoma
- Clinical Development of Topoisomerase-Interactive Drugs
- Brief Treatment Modalities of Alopecia Areata: Review Article
- Dermatologic manifestations of endocrine disorders
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- How to diagnose a lipodystrophy syndrome
- Symptom management in inflammatory bowel disease
- Index
- Neuroendocrinology of the hair follicle: principles and clinical perspectives
- Prolactin and the Skin: A Dermatological Perspective on an Ancient Pleiotropic Peptide Hormone
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Drug repositioning using <i>in silico</i> compound profiling
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- The acne hormones
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis
- Alopecia With Endocrine Therapies in Patients With Cancer